Rapid Identification of a Platelet-Derived Alzheimer's Disease- Specific Phenotype by Biochip Array Technology
M. Veitinger, R. Oehler, E. Umlauf, R. Baumgartner, A. Graf, G. Mitulovic, E. Rappold, P. Lowry, J. Lamont, M. Zellner


Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?
Veitinger M, Varga B, Guterres SB, Zellner M
Acta Neuropathol Commun. 2014 Jun 16;2:65


Identification and validation of platelet low biological variation proteins, superior to GAPDH, actin and tubulin, as tools in clinical proteomics
Baumgartner R, Umlauf E, Veitinger M, Guterres S, Rappold E, Babeluk R, Mitulović G, Oehler R, Zellner M.


Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients
Zellner M, Baureder M, Rappold E, Bugert P, Kotzailias N, Babeluk R, Baumgartner R, Attems J, Gerner C, Jellinger K, Roth E, Oehler R, Umlauf E.


A proteomics study reveals a predominant change in MaoB expression in platelets of healthy volunteers after high protein meat diet: relationship to the methylation cycle
ZellnerM, Babeluk R, Jakobsen LH, Gerner C, Umlauf E, Volf I, Roth E, Kondrup J.


The role of proteomics in dementia and Alzheimer's disease
Zellner M, Veitinger M, Umlauf E.




Scientific Objective


Work Packages



Progress Reports

Clinical Cooperations

The Team